Clinical Trials Browser

Phase 1/2 × Vomiting × fosaprepitant × Clear all

NCT01031953 2017-05-09

Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy

Phase 1/2 Terminated

34 enrolled 12 charts

Nausea, Vomiting